Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors
Clinical trial NCT06533605 · UNKNOWN
Trial details
- NCT number
- NCT06533605
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-07-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.